SG50625A1 - Thioxanthenone antitumor agents - Google Patents

Thioxanthenone antitumor agents

Info

Publication number
SG50625A1
SG50625A1 SG1996007125A SG1996007125A SG50625A1 SG 50625 A1 SG50625 A1 SG 50625A1 SG 1996007125 A SG1996007125 A SG 1996007125A SG 1996007125 A SG1996007125 A SG 1996007125A SG 50625 A1 SG50625 A1 SG 50625A1
Authority
SG
Singapore
Prior art keywords
alkyl
hydrogen
ch2n
antitumor agents
thioxanthenones
Prior art date
Application number
SG1996007125A
Other languages
English (en)
Inventor
Joseph Charles Collins
Kenneth Charles Mattes
Mark Philip Wantland
Robert Bruno Perni
Theodore Charles Miller
Thomas Hughes Corbett
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of SG50625A1 publication Critical patent/SG50625A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655363Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
    • C07F9/655372Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • C07D335/12Thioxanthenes
    • C07D335/14Thioxanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D335/16Oxygen atoms, e.g. thioxanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG1996007125A 1991-06-10 1992-06-03 Thioxanthenone antitumor agents SG50625A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71317391A 1991-06-10 1991-06-10
US83515992A 1992-02-13 1992-02-13

Publications (1)

Publication Number Publication Date
SG50625A1 true SG50625A1 (en) 1998-07-20

Family

ID=27108950

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007125A SG50625A1 (en) 1991-06-10 1992-06-03 Thioxanthenone antitumor agents

Country Status (20)

Country Link
EP (1) EP0518414B1 (de)
JP (1) JP3045354B2 (de)
KR (1) KR100209826B1 (de)
AT (1) ATE106882T1 (de)
AU (1) AU642596B2 (de)
CA (1) CA2070120C (de)
DE (1) DE69200179T2 (de)
DK (1) DK0518414T3 (de)
ES (1) ES2055635T3 (de)
FI (1) FI114024B (de)
HU (1) HU218655B (de)
IE (1) IE66828B1 (de)
IL (1) IL102139A (de)
MX (1) MX9202753A (de)
NO (1) NO302364B1 (de)
NZ (1) NZ242862A (de)
PH (1) PH30883A (de)
RU (1) RU2075477C1 (de)
SG (1) SG50625A1 (de)
TW (1) TW218015B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091410A (en) * 1991-06-10 1992-02-25 Sterling Winthrop Inc. Thioxanthenone antitumor agents
US5346917A (en) * 1991-06-10 1994-09-13 Sterling Winthrop Inc. Thioxanthenone antitumor agents
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
EP2175854A4 (de) * 2007-07-31 2012-02-29 Univ North Dakota Res Foundation Verbessertes verfahren für die synthese substituierter formylamine und substituierter amine
FR2979823B1 (fr) * 2011-09-13 2013-09-27 Pf Medicament Utilisation du 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methyl-propyl]amino-3,4-dihydro-2h-1,5-benzoxathiepine pour le traitement du cancer et en particulier pour la prevention et/ou le traitement des metastases cancereuses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745172A (en) * 1970-10-05 1973-07-10 Sterling Drug Inc 1-(di-(lower-alkyl)aminoalkylamino)-9-oxothioxanthenes
US4539412A (en) * 1982-07-08 1985-09-03 Rensselaer Polytechnic Institute 7-Hydroxylucanthone, 7-hydroxhycanthone and their analogs
US5091410A (en) * 1991-06-10 1992-02-25 Sterling Winthrop Inc. Thioxanthenone antitumor agents

Also Published As

Publication number Publication date
JPH05178853A (ja) 1993-07-20
NO922273D0 (no) 1992-06-10
FI922694A0 (fi) 1992-06-10
DE69200179T2 (de) 1995-01-19
DE69200179D1 (de) 1994-07-14
HU218655B (hu) 2000-10-28
DK0518414T3 (da) 1994-08-15
FI114024B (fi) 2004-07-30
MX9202753A (es) 1993-01-01
IL102139A0 (en) 1993-01-14
IE66828B1 (en) 1996-02-07
CA2070120C (en) 2005-11-15
ES2055635T3 (es) 1994-08-16
KR930000499A (ko) 1993-01-15
HUT61992A (en) 1993-03-29
IL102139A (en) 1997-03-18
PH30883A (en) 1997-12-23
AU1704692A (en) 1992-12-17
NZ242862A (en) 1993-09-27
EP0518414B1 (de) 1994-06-08
HU9201926D0 (en) 1992-08-28
IE921871A1 (en) 1992-12-16
KR100209826B1 (ko) 1999-07-15
NO922273L (no) 1992-12-11
CA2070120A1 (en) 1992-12-11
ATE106882T1 (de) 1994-06-15
TW218015B (de) 1993-12-21
JP3045354B2 (ja) 2000-05-29
NO302364B1 (no) 1998-02-23
FI922694A (fi) 1992-12-11
RU2075477C1 (ru) 1997-03-20
AU642596B2 (en) 1993-10-21
EP0518414A1 (de) 1992-12-16

Similar Documents

Publication Publication Date Title
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
HU9601217D0 (en) Antracyclinone derivatives and their use for treating amyloidosis
IL109241A0 (en) Thioxanthenone derivatives and pharmaceutical compositions containing them
TW218015B (de)
HUT72897A (en) Indole derivatives having antitumor activity and pharmaceutical composition containing them
TW254937B (en) Benzocycloheptene derivative and process for preparation thereof
ES8506032A1 (es) Un procedimiento para la preparacion de un derivado de ergolina